AlphaFold predicted structure
ITPKB · P27987

Mean pLDDT
55.3/ 100
Low
946 residues
Confidence breakdown
- Very high(≥ 90)23%
- Confident(70–90)9%
- Low(50–70)4%
- Very low(< 50)64%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
inositol-trisphosphate 3-kinase B
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalParkinson disease
neurodegenerative disease
asthma
myeloproliferative neoplasm, unclassifiable
respiratory system disorder
allergic disease
Abnormality of refraction
Alzheimer disease
multiple sclerosis
lysosomal storage disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Inositol-trisphosphate 3-kinase B
Catalyzes the phosphorylation of 1D-myo-inositol 1,4,5-trisphosphate (InsP3) into 1D-myo-inositol 1,3,4,5-tetrakisphosphate and participates to the regulation of calcium homeostasis
ITPKB · P27987

Mean pLDDT
55.3/ 100
Low
946 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0